SURG vs GLIBA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 30, 2026
SURG
GLIBA
Investment Advisor Scores
GLIBA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | SURG | GLIBA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 3.3546 | 10.4058 | SURG |
| PEG Ratio | 0.5333 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 40.7% | 0.0% | SURG |
| Earnings Growth | -77.7% | -54.0% | GLIBA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 51.9/100 | 33.4/100 | SURG |
| Profit Margin | -47.9% | -32.5% | GLIBA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | SELL | SURG |
Relative Price Performance (Last 90 Days)
Current Technical Phase
SURG
MarkdownPrice below a falling SMA50 (slope -26.6%), weak momentum, RSI 34
GLIBA
MarkupPrice above SMA50, rising 50-day trend (7.1% over 20 days), RSI 64
Fundamentals Snapshot
| Metric | SURG | GLIBA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 3.3 | 8.4 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 0.0% |
| Gross Margin | -0.2% | 0.5% |
| Operating Margin | 0.2% | 0.1% |
| EPS | -1.49 | -8.42 |
| Dividend Yield | — | — |